Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background

A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis and related disorders 2024-05, Vol.85, p.105544, Article 105544
1. Verfasser: Budhram, Adrian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 105544
container_title Multiple sclerosis and related disorders
container_volume 85
creator Budhram, Adrian
description A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.
doi_str_mv 10.1016/j.msard.2024.105544
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2956163227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211034824001238</els_id><sourcerecordid>2956163227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-be3a9bd30212a68ee574f4c1a24a0a28b79e5575d16a27809da6646e4a495af13</originalsourceid><addsrcrecordid>eNp9kM1u1DAUhS0EolXpEyAhL1kwg_-TILEYlbYgFXUDa-vGuRk8JPZgOxWsePV6OqVLvPHV0Xd8rg8hrzlbc8bN-916zpCGtWBCVUVrpZ6RUyE4XzGpzfOnWbUn5DznHavHaK4Mf0lOZKtMwzp-Sv5e_nbTkn0MNI4UpoIpQPF3SAcP2xAz5g90Q12c9zFgKAeq_EBacyX9enu9-URd8tXloepQaI9TDNtM63jgxphwTDGUdzTEQn14UHtwP7cpLmF4RV6MMGU8f7zPyPery28Xn1c3t9dfLjY3KydZV1Y9Suj6QTLBBZgWUTdqVI6DUMBAtH3TodaNHrgB0bSsG8AYZVCB6jSMXJ6Rt8d39yn-WjAXO_vscJogYFyyFZ023EghmorKI-pSzLmub_fJz5D-WM7soXy7sw_l20P59lh-db15DFj6GYcnz7-qK_DxCGD95p3HZLPzGBwOPqErdoj-vwH3AHaVpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2956163227</pqid></control><display><type>article</type><title>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</title><source>Alma/SFX Local Collection</source><creator>Budhram, Adrian</creator><creatorcontrib>Budhram, Adrian</creatorcontrib><description>A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.</description><identifier>ISSN: 2211-0348</identifier><identifier>ISSN: 2211-0356</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2024.105544</identifier><identifier>PMID: 38467091</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Autoantibody ; Diagnostic criteria ; MOG ; Myelin oligodendrocyte glycoprotein ; Neural antibody</subject><ispartof>Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105544, Article 105544</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-be3a9bd30212a68ee574f4c1a24a0a28b79e5575d16a27809da6646e4a495af13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38467091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Budhram, Adrian</creatorcontrib><title>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><description>A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.</description><subject>Autoantibody</subject><subject>Diagnostic criteria</subject><subject>MOG</subject><subject>Myelin oligodendrocyte glycoprotein</subject><subject>Neural antibody</subject><issn>2211-0348</issn><issn>2211-0356</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u1DAUhS0EolXpEyAhL1kwg_-TILEYlbYgFXUDa-vGuRk8JPZgOxWsePV6OqVLvPHV0Xd8rg8hrzlbc8bN-916zpCGtWBCVUVrpZ6RUyE4XzGpzfOnWbUn5DznHavHaK4Mf0lOZKtMwzp-Sv5e_nbTkn0MNI4UpoIpQPF3SAcP2xAz5g90Q12c9zFgKAeq_EBacyX9enu9-URd8tXloepQaI9TDNtM63jgxphwTDGUdzTEQn14UHtwP7cpLmF4RV6MMGU8f7zPyPery28Xn1c3t9dfLjY3KydZV1Y9Suj6QTLBBZgWUTdqVI6DUMBAtH3TodaNHrgB0bSsG8AYZVCB6jSMXJ6Rt8d39yn-WjAXO_vscJogYFyyFZ023EghmorKI-pSzLmub_fJz5D-WM7soXy7sw_l20P59lh-db15DFj6GYcnz7-qK_DxCGD95p3HZLPzGBwOPqErdoj-vwH3AHaVpg</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Budhram, Adrian</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240501</creationdate><title>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</title><author>Budhram, Adrian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-be3a9bd30212a68ee574f4c1a24a0a28b79e5575d16a27809da6646e4a495af13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Autoantibody</topic><topic>Diagnostic criteria</topic><topic>MOG</topic><topic>Myelin oligodendrocyte glycoprotein</topic><topic>Neural antibody</topic><toplevel>online_resources</toplevel><creatorcontrib>Budhram, Adrian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Budhram, Adrian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>85</volume><spage>105544</spage><pages>105544-</pages><artnum>105544</artnum><issn>2211-0348</issn><issn>2211-0356</issn><eissn>2211-0356</eissn><abstract>A recent study evaluating the diagnostic performance of the 2023 MOGAD criteria found that it had relatively low specificity. However, this study did not apply the component of these criteria that requires exclusion of alternative diagnoses (item C) when evaluating its performance, raising questions surrounding the relevance of the study's findings to the use of these criteria in routine practice. This correspondence acknowledges the challenge of clinically applying this component of diagnostic criteria, discusses what exclusion of alterative diagnoses actually entails conceptually, and emphasizes the importance of its inclusion in future studies aimed at evaluating the performance of proposed criteria.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38467091</pmid><doi>10.1016/j.msard.2024.105544</doi></addata></record>
fulltext fulltext
identifier ISSN: 2211-0348
ispartof Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105544, Article 105544
issn 2211-0348
2211-0356
2211-0356
language eng
recordid cdi_proquest_miscellaneous_2956163227
source Alma/SFX Local Collection
subjects Autoantibody
Diagnostic criteria
MOG
Myelin oligodendrocyte glycoprotein
Neural antibody
title Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exclusion%20of%20alternative%20diagnoses:%20A%20component%20of%20the%202023%20MOGAD%20criteria%20that%20belongs%20at%20the%20forefront,%20not%20in%20the%20background&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Budhram,%20Adrian&rft.date=2024-05-01&rft.volume=85&rft.spage=105544&rft.pages=105544-&rft.artnum=105544&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2024.105544&rft_dat=%3Cproquest_cross%3E2956163227%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2956163227&rft_id=info:pmid/38467091&rft_els_id=S2211034824001238&rfr_iscdi=true